Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from QuantumPharm, Inc. ( (HK:2228) ) is now available.
XtalPi Holdings Limited, a company listed on the Hong Kong Stock Exchange, issued a clarification announcement regarding its interim results for the six months ended June 30, 2025. The company corrected errors in the reported number of ordinary shares and earnings per share figures, which were initially misstated in their interim results announcement. The corrected figures indicate a higher earnings per share than previously reported, which may positively impact stakeholders’ perception of the company’s financial performance.
The most recent analyst rating on (HK:2228) stock is a Hold with a HK$10.50 price target. To see the full list of analyst forecasts on QuantumPharm, Inc. stock, see the HK:2228 Stock Forecast page.
More about QuantumPharm, Inc.
Average Trading Volume: 167,274,637
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$43.18B
For a thorough assessment of 2228 stock, go to TipRanks’ Stock Analysis page.